While this happened, Rodman & Renshaw initiated its Milestone Pharmaceuticals Inc [MIST] rating to a Buy in a research note published on August 22, 2024; the price target was $9. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid June from “a Buy” to “a Hold”. Piper Sandler also remained covering MIST and has increased its forecast on April 22, 2022 with a “an Overweight” recommendation from previously “Neutral” rating. H.C. Wainwright started covering the stock on March 05, 2021. It rated MIST as “a Buy”.
Price Performance Review of MIST
On Monday, Milestone Pharmaceuticals Inc [NASDAQ:MIST] saw its stock jump 13.62% to $1.01. Over the last five days, the stock has gained 30.95%. Milestone Pharmaceuticals Inc shares have fallen nearly -57.20% since the year began. Nevertheless, the stocks have fallen -42.29% over the past one year. While a 52-week high of $2.75 was reached on 03/17/25, a 52-week low of $0.63 was recorded on 04/09/25. SMA at 50 days reached $1.6184, while 200 days put it at $1.6526.
Levels Of Support And Resistance For MIST Stock
The 24-hour chart illustrates a support level at 0.9167, which if violated will result in even more drops to 0.8233. On the upside, there is a resistance level at 1.0667. A further resistance level may holdings at 1.1233. The Relative Strength Index (RSI) on the 14-day chart is 43.75, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1223, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 5.00%. Stochastics %K at 86.93% indicates the stock is a selling.
How much short interest is there in Milestone Pharmaceuticals Inc?
A steep rise in short interest was recorded in Milestone Pharmaceuticals Inc stocks on 2025-03-31, growing by 1.82 million shares to a total of 2.56 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 0.74 million shares. There was a rise of 71.0%, which implies that there is a positive sentiment for the stock.
